ClinicalTrials.gov
ClinicalTrials.gov Menu

Studying a Quality of Life Questionnaire in Patients With Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00564694
Recruitment Status : Completed
First Posted : November 28, 2007
Last Update Posted : October 29, 2013
Sponsor:
Information provided by:
National Cancer Institute (NCI)

Brief Summary:

RATIONALE: Collecting information about the quality of life of patients with colorectal cancer may help doctors learn more about the disease.

PURPOSE: This clinical trial is studying the European Organization of Research for the Treatment of Cancer (EORTC) quality-of-life-questionnaire in patients with colorectal cancer.


Condition or disease Intervention/treatment
Colorectal Cancer Procedure: psychosocial assessment and care Procedure: quality-of-life assessment

Detailed Description:

OBJECTIVES:

  • To test the reliability and clinical and psychometric validity of the European Organization of Research for the Treatment of Cancer (EORTC) quality of life questionnaire (QLQ-CR29) in an international sample of patients with colorectal cancer.

OUTLINE: This is a multicenter study. Patients are stratified into predetermined clinically distinct groups (colon cancer after surgery vs colon cancer undergoing adjuvant chemotherapy vs rectal cancer undergoing neoadjuvant radiotherapy vs rectal cancer after anterior resection with temporary stoma vs rectal cancer after abdominoperineal excision of rectum vs colorectal cancer undergoing palliative chemotherapy).

Quality-of-life data is collected alongside standard outcomes in patients undergoing treatment for colorectal cancer. Patients complete the European Organization of Research for the Treatment of Cancer (EORTC) quality of life questionnaire (QLQ-C30), the revised colorectal cancer module (QLQ-CR29), case report forms for clinical and sociodemographic data, and a debriefing questionnaire at different time points before, during, and after treatment. Some patients complete more sets of the same questionnaire at later time points to assess sensitivity to change over time and test-retest reliability. Reliability, and clinical and psychometric validity of the questionnaires are assessed by correlation analyses, exploration of known group comparisons, and responsiveness to clinical changes.


Study Type : Observational
Estimated Enrollment : 350 participants
Official Title: Validation of an EORTC Quality of Life Questionnaire Module for Patients With Colorectal Cancer
Study Start Date : May 2007
Actual Primary Completion Date : June 2009

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. Reliability and clinical and psychometric validity of the European Organization of Research for the Treatment of Cancer (EORTC) quality of life questionnaire (QLQ-CR29)


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

DISEASE CHARACTERISTICS:

  • Histologically confirmed adenocarcinoma of the colon or rectum
  • No brain metastases or intracranial tumor extension with cognitive impairment

PATIENT CHARACTERISTICS:

  • No limit on performance status
  • Able to understand the language of the questionnaire
  • No psychological, familial, sociological, or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
  • No other concurrent malignancies except basal cell carcinoma of the skin

PRIOR CONCURRENT THERAPY:

  • No prior participation in this study (in a different subgroup)
  • No concurrent participation in other quality of life studies that might interfere with this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564694


Locations
France
Centre Alexis Vautrin
Vandoeuvre-les-Nancy, France, 54511
Germany
Charite University Medical Center of Berlin
Berlin, Germany, D-13347
Klinikum der Universitaet Regensburg
Regensburg, Germany, D-93053
United Kingdom
Basingstoke and North Hampshire NHS Foundation Trust
Basingstoke, England, United Kingdom, RG24 9NA
Bristol Haematology and Oncology Centre
Bristol, England, United Kingdom, BS2 8ED
Sponsors and Collaborators
National Cancer Institute (NCI)
Investigators
Study Chair: Jane Blazeby, MB, CHB, FRCS, BSc, MD University Hospitals Bristol NHS Foundation Trust

Publications of Results:
ClinicalTrials.gov Identifier: NCT00564694     History of Changes
Other Study ID Numbers: CDR0000574769
EORTC-QLQ-CR29
EU-20783
First Posted: November 28, 2007    Key Record Dates
Last Update Posted: October 29, 2013
Last Verified: August 2009

Keywords provided by National Cancer Institute (NCI):
adenocarcinoma of the colon
recurrent colon cancer
stage I colon cancer
stage II colon cancer
stage III colon cancer
stage IV colon cancer
adenocarcinoma of the rectum
recurrent rectal cancer
stage I rectal cancer
stage II rectal cancer
stage III rectal cancer
stage IV rectal cancer

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases